Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 5
1951 3
1952 2
1953 5
1954 1
1955 6
1956 4
1957 1
1958 2
1959 2
1960 2
1961 2
1962 1
1963 10
1964 4
1965 4
1966 8
1967 9
1968 10
1969 6
1970 7
1971 11
1972 7
1973 11
1974 7
1975 12
1976 9
1977 18
1978 14
1979 7
1980 9
1981 7
1982 6
1983 11
1984 16
1985 13
1986 18
1987 13
1988 21
1989 20
1990 15
1991 17
1992 16
1993 34
1994 35
1995 22
1996 25
1997 20
1998 27
1999 17
2000 23
2001 16
2002 26
2003 15
2004 27
2005 21
2006 14
2007 31
2008 30
2009 21
2010 34
2011 33
2012 28
2013 27
2014 28
2015 36
2016 24
2017 35
2018 39
2019 40
2020 52
2021 52
2022 43
2023 38
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,229 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, Shinnar S, Conwit R, Meinzer C, Cock H, Fountain N, Connor JT, Silbergleit R; NETT and PECARN Investigators. Kapur J, et al. Among authors: chamberlain jm. N Engl J Med. 2019 Nov 28;381(22):2103-2113. doi: 10.1056/NEJMoa1905795. N Engl J Med. 2019. PMID: 31774955 Free PMC article. Clinical Trial.
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R; Neurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Chamberlain JM, et al. Lancet. 2020 Apr 11;395(10231):1217-1224. doi: 10.1016/S0140-6736(20)30611-5. Epub 2020 Mar 20. Lancet. 2020. PMID: 32203691 Free PMC article. Clinical Trial.
Split intein-mediated protein trans-splicing to express large dystrophins.
Tasfaout H, Halbert CL, McMillen TS, Allen JM, Reyes TR, Flint GV, Grimm D, Hauschka SD, Regnier M, Chamberlain JS. Tasfaout H, et al. Among authors: chamberlain js. Nature. 2024 Aug;632(8023):192-200. doi: 10.1038/s41586-024-07710-8. Epub 2024 Jul 17. Nature. 2024. PMID: 39020181 Free PMC article.
Viral vector-mediated gene therapies.
Hollinger K, Chamberlain JS. Hollinger K, et al. Among authors: chamberlain js. Curr Opin Neurol. 2015 Oct;28(5):522-7. doi: 10.1097/WCO.0000000000000241. Curr Opin Neurol. 2015. PMID: 26263476 Free PMC article. Review.
Duchenne muscular dystrophy.
Chamberlain JS. Chamberlain JS. Curr Opin Genet Dev. 1991 Jun;1(1):11-4. doi: 10.1016/0959-437x(91)80033-i. Curr Opin Genet Dev. 1991. PMID: 1840869 Free article. Review.
In vivo selection of synthetic nucleocapsids for tissue targeting.
Olshefsky A, Benasutti H, Sylvestre M, Butterfield GL, Rocklin GJ, Richardson C, Hicks DR, Lajoie MJ, Song K, Leaf E, Treichel C, Decarreau J, Ke S, Kher G, Carter L, Chamberlain JS, Baker D, King NP, Pun SH. Olshefsky A, et al. Among authors: chamberlain js. Proc Natl Acad Sci U S A. 2023 Nov 14;120(46):e2306129120. doi: 10.1073/pnas.2306129120. Epub 2023 Nov 8. Proc Natl Acad Sci U S A. 2023. PMID: 37939083 Free PMC article.
Efficacy and muscle safety assessment of fukutin-related protein gene therapy.
Benasutti H, Maricelli JW, Seto J, Hall J, Halbert C, Wicki J, Heusgen L, Purvis N, Regnier M, Lin DC, Rodgers BD, Chamberlain JS. Benasutti H, et al. Among authors: chamberlain js. Mol Ther Methods Clin Dev. 2023 Jun 4;30:65-80. doi: 10.1016/j.omtm.2023.05.022. eCollection 2023 Sep 14. Mol Ther Methods Clin Dev. 2023. PMID: 37361354 Free PMC article.
Progress toward Gene Therapy for Duchenne Muscular Dystrophy.
Chamberlain JR, Chamberlain JS. Chamberlain JR, et al. Among authors: chamberlain js. Mol Ther. 2017 May 3;25(5):1125-1131. doi: 10.1016/j.ymthe.2017.02.019. Epub 2017 Apr 15. Mol Ther. 2017. PMID: 28416280 Free PMC article. Review.
Therapeutic approaches to muscular dystrophy.
Goyenvalle A, Seto JT, Davies KE, Chamberlain J. Goyenvalle A, et al. Among authors: chamberlain j. Hum Mol Genet. 2011 Apr 15;20(R1):R69-78. doi: 10.1093/hmg/ddr105. Epub 2011 Mar 24. Hum Mol Genet. 2011. PMID: 21436158 Free PMC article. Review.
1,229 results